Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients with Intermittent Claudication Injected with ALDH Bright Cells)
Emerson C. Perin, Michael P. Murphy, Keith L. March, Roberto Bolli, John Loughran, Phillip C. Yang, Nicholas J. Leeper, Ronald L. Dalman, Jason Alexander, Timothy D. Henry, Jay H. Traverse, Carl J. Pepine, R. David Anderson, Scott Berceli, James T. Willerson, Raja Muthupillai, Amir Gahremanpour, Ganesh Raveendran, Omaida Velasquez, Joshua M. HareIvonne Hernandez Schulman, Vijaykumar S. Kasi, William R. Hiatt, Bharath Ambale-Venkatesh, João A. Lima, Doris A. Taylor, Micheline Resende, Adrian P. Gee, April G. Durett, Jeanette Bloom, Sara Richman, Patricia G'Sell, Shari Williams, Fouzia Khan, Elsie Gyang Ross, Michelle R. Santoso, Joanne Goldman, Dana Leach, Eileen Handberg, Benjamin Cheong, Nichole Piece, Darcy Difede, Barb Bruhn-Ding, Emily Caldwell, Judy Bettencourt, Dejian Lai, Linda Piller, Lara Simpson, Michelle Cohen, Shelly L. Sayre, Rachel W. Vojvodic, Lem Moyé, Ray F. Ebert, Robert D. Simari, Alan T. Hirsch
Dive into the research topics of 'Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients with Intermittent Claudication Injected with ALDH Bright Cells)'. Together they form a unique fingerprint.